A study published Monday in Nature showed that Merck’s COVID-19 pill molnupiravir induces mutations that can lead to new SARS-CoV-2 variants. Numerous doctors and scientists voiced concerns about the drug’s mutagenicity before it was approved in 2021.

Dr. Harvey Risch, professor emeritus of epidemiology and senior research scientist at the Yale School of Public Health, told The Defender the study was “very high-quality research” and that the results are “another ‘duh’ moment.”

Risch said:

“A number of us, myself included, predicted from its mechanism of action that this would be the result when molnupiravir was approved and rolled out. Hence the ‘duh’ — it was obvious. Obvious to everyone except the FDA [U.S. Food and Drug Administration] that is locked into pharma corruption.”

https://childrenshealthdefense.org/defender/merck-molnupiravir-covid-variants/?

AND

https://www.nature.com/articles/s41586-023-06649-6.epdf?